LAMEA Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024

List of Tables

The Latin America, Middle East and Africa Clinical Risk Grouping Solution Market would witness market growth of 14.9% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Clinical Risk Grouping Solution Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $27.7 million by 2031. The Argentina market is showcasing a CAGR of 15.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 13.9% during (2024 - 2031).

the application of clinical risk grouping in personalized medicine extends beyond oncology. In areas such as cardiology, endocrinology, and neurology, these solutions are used to develop personalized treatment plans that address patients' specific risks and needs.

Moreover, in cardiology, a patient with a genetic predisposition to heart disease might be monitored more closely and prescribed preventive measures, such as lifestyle changes or medications, to reduce their risk of developing serious cardiovascular conditions. In diabetes management, clinical risk grouping can assist in the identification of patients who are at a higher risk of complications.

The necessity for sophisticated instruments to improve patient care, optimize resource allocation, and reduce healthcare costs is increasingly acknowledged as healthcare systems in LAMEA continue to develop. In Brazil, the rising prevalence of chronic diseases significantly drives the demand for clinical risk grouping solutions. According to the Brazilian Ministry of Health, chronic diseases such as diabetes, hypertension, and cardiovascular conditions are leading causes of death in the country, affecting millions of Brazilians. Brazilian healthcare providers increasingly adopt clinical risk grouping solutions to combat this growing health crisis and better identify high-risk patients.

Based on Product, the market is segmented into Software and Services. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Long Term Care Centers, and Other. Based on Deployment, the market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. Based on Application, the market is segmented into Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Conduent, Incorporated
3M Company
Oracle Corporation (Cerner Corporation)
Microsoft Corporation (Nuance Communications, Inc.)
Health Catalyst, Inc.
Koninklijke Philips N.V.
Siemens Healthineers AG (Siemens AG)
HBI Solutions
Lightbeam Health Solutions
Reveleer

LAMEA Clinical Risk Grouping Solution Market Report Segmentation

By Product

Software
Services

By End-use

Hospitals & Clinics
Ambulatory Surgical Centers
Long Term Care Centers
Other

By Deployment

Private Cloud
Public Cloud
Hybrid Cloud

By Application

Population Health Management
Chronic Disease Management
Clinical Decision Support
Fraud Detection and Prevention
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Clinical Risk Grouping Solution Market, by Product
- 1.4.2 LAMEA Clinical Risk Grouping Solution Market, by End-use
- 1.4.3 LAMEA Clinical Risk Grouping Solution Market, by Deployment
- 1.4.4 LAMEA Clinical Risk Grouping Solution Market, by Application
- 1.4.5 LAMEA Clinical Risk Grouping Solution Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities:
- 3.2.4 Market Challenges:

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar - 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. LAMEA Clinical Risk Grouping Solution Market by Product

5.1 LAMEA Software Market by Country
5.2 LAMEA Services Market by Country

Chapter 6. LAMEA Clinical Risk Grouping Solution Market by End-use

6.1 LAMEA Hospitals & Clinics Market by Country
6.2 LAMEA Ambulatory Surgical Centers Market by Country
6.3 LAMEA Long Term Care Centers Market by Country
6.4 LAMEA Other Market by Country

Chapter 7. LAMEA Clinical Risk Grouping Solution Market by Deployment

7.1 LAMEA Private Cloud Market by Country
7.2 LAMEA Public Cloud Market by Country
7.3 LAMEA Hybrid Cloud Market by Country

Chapter 8. LAMEA Clinical Risk Grouping Solution Market by Application

8.1 LAMEA Population Health Management Market by Country
8.2 LAMEA Chronic Disease Management Market by Country
8.3 LAMEA Clinical Decision Support Market by Country
8.4 LAMEA Fraud Detection and Prevention Market by Country
8.5 LAMEA Others Market by Country

Chapter 9. LAMEA Clinical Risk Grouping Solution Market by Country

9.1 Brazil Clinical Risk Grouping Solution Market
- 9.1.1 Brazil Clinical Risk Grouping Solution Market by Product
- 9.1.2 Brazil Clinical Risk Grouping Solution Market by End-use
- 9.1.3 Brazil Clinical Risk Grouping Solution Market by Deployment
- 9.1.4 Brazil Clinical Risk Grouping Solution Market by Application
9.2 Argentina Clinical Risk Grouping Solution Market
- 9.2.1 Argentina Clinical Risk Grouping Solution Market by Product
- 9.2.2 Argentina Clinical Risk Grouping Solution Market by End-use
- 9.2.3 Argentina Clinical Risk Grouping Solution Market by Deployment
- 9.2.4 Argentina Clinical Risk Grouping Solution Market by Application
9.3 UAE Clinical Risk Grouping Solution Market
- 9.3.1 UAE Clinical Risk Grouping Solution Market by Product
- 9.3.2 UAE Clinical Risk Grouping Solution Market by End-use
- 9.3.3 UAE Clinical Risk Grouping Solution Market by Deployment
- 9.3.4 UAE Clinical Risk Grouping Solution Market by Application
9.4 Saudi Arabia Clinical Risk Grouping Solution Market
- 9.4.1 Saudi Arabia Clinical Risk Grouping Solution Market by Product
- 9.4.2 Saudi Arabia Clinical Risk Grouping Solution Market by End-use
- 9.4.3 Saudi Arabia Clinical Risk Grouping Solution Market by Deployment
- 9.4.4 Saudi Arabia Clinical Risk Grouping Solution Market by Application
9.5 South Africa Clinical Risk Grouping Solution Market
- 9.5.1 South Africa Clinical Risk Grouping Solution Market by Product
- 9.5.2 South Africa Clinical Risk Grouping Solution Market by End-use
- 9.5.3 South Africa Clinical Risk Grouping Solution Market by Deployment
- 9.5.4 South Africa Clinical Risk Grouping Solution Market by Application
9.6 Nigeria Clinical Risk Grouping Solution Market
- 9.6.1 Nigeria Clinical Risk Grouping Solution Market by Product
- 9.6.2 Nigeria Clinical Risk Grouping Solution Market by End-use
- 9.6.3 Nigeria Clinical Risk Grouping Solution Market by Deployment
- 9.6.4 Nigeria Clinical Risk Grouping Solution Market by Application
9.7 Rest of LAMEA Clinical Risk Grouping Solution Market
- 9.7.1 Rest of LAMEA Clinical Risk Grouping Solution Market by Product
- 9.7.2 Rest of LAMEA Clinical Risk Grouping Solution Market by End-use
- 9.7.3 Rest of LAMEA Clinical Risk Grouping Solution Market by Deployment
- 9.7.4 Rest of LAMEA Clinical Risk Grouping Solution Market by Application

Chapter 10. Company Profiles

10.1 Conduent, Incorporated
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expenses
10.2 3M Company
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
  - 10.2.5.1 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
10.3 Oracle Corporation (Cerner Corporation)
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
  - 10.3.5.1 Product Launches and Product Expansions:
- 10.3.6 SWOT Analysis
10.4 Microsoft Corporation (Nuance Communications, Inc.)
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental and Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
  - 10.4.5.1 Product Launches and Product Expansions:
- 10.4.6 SWOT Analysis
10.5 Health Catalyst, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 Recent strategies and developments:
  - 10.5.5.1 Product Launches and Product Expansions:
  - 10.5.5.2 Acquisition and Mergers:
- 10.5.6 SWOT Analysis
10.6 Koninklijke Philips N.V.
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.6.5 Recent strategies and developments:
  - 10.6.5.1 Product Launches and Product Expansions:
  - 10.6.5.2 Acquisition and Mergers:
- 10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 SWOT Analysis
10.8 HBI Solutions
- 10.8.1 Company Overview
10.9 Lightbeam Health Solutions
- 10.9.1 Company Overview
- 10.9.2 Recent strategies and developments:
  - 10.9.2.1 Partnerships, Collaborations, and Agreements:
  - 10.9.2.2 Acquisition and Mergers:
10.10. Reveleer
- 10.10.1 Company Overview
- 10.10.2 Recent strategies and developments:
  - 10.10.2.1 Acquisition and Mergers:

LIST OF TABLES

TABLE 1 LAMEA Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Enterprise Key Management Market
TABLE 4 Product Launches And Product Expansions- Enterprise Key Management Market
TABLE 5 Acquisition and Mergers- Enterprise Key Management Market
TABLE 6 LAMEA Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 7 LAMEA Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 8 LAMEA Software Market by Country, 2020 - 2023, USD Million
TABLE 9 LAMEA Software Market by Country, 2024 - 2031, USD Million
TABLE 10 LAMEA Services Market by Country, 2020 - 2023, USD Million
TABLE 11 LAMEA Services Market by Country, 2024 - 2031, USD Million
TABLE 12 LAMEA Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 13 LAMEA Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 14 LAMEA Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 15 LAMEA Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 16 LAMEA Ambulatory Surgical Centers Market by Country, 2020 - 2023, USD Million
TABLE 17 LAMEA Ambulatory Surgical Centers Market by Country, 2024 - 2031, USD Million
TABLE 18 LAMEA Long Term Care Centers Market by Country, 2020 - 2023, USD Million
TABLE 19 LAMEA Long Term Care Centers Market by Country, 2024 - 2031, USD Million
TABLE 20 LAMEA Other Market by Country, 2020 - 2023, USD Million
TABLE 21 LAMEA Other Market by Country, 2024 - 2031, USD Million
TABLE 22 LAMEA Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 23 LAMEA Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 24 LAMEA Private Cloud Market by Country, 2020 - 2023, USD Million
TABLE 25 LAMEA Private Cloud Market by Country, 2024 - 2031, USD Million
TABLE 26 LAMEA Public Cloud Market by Country, 2020 - 2023, USD Million
TABLE 27 LAMEA Public Cloud Market by Country, 2024 - 2031, USD Million
TABLE 28 LAMEA Hybrid Cloud Market by Country, 2020 - 2023, USD Million
TABLE 29 LAMEA Hybrid Cloud Market by Country, 2024 - 2031, USD Million
TABLE 30 LAMEA Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 31 LAMEA Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 32 LAMEA Population Health Management Market by Country, 2020 - 2023, USD Million
TABLE 33 LAMEA Population Health Management Market by Country, 2024 - 2031, USD Million
TABLE 34 LAMEA Chronic Disease Management Market by Country, 2020 - 2023, USD Million
TABLE 35 LAMEA Chronic Disease Management Market by Country, 2024 - 2031, USD Million
TABLE 36 LAMEA Clinical Decision Support Market by Country, 2020 - 2023, USD Million
TABLE 37 LAMEA Clinical Decision Support Market by Country, 2024 - 2031, USD Million
TABLE 38 LAMEA Fraud Detection and Prevention Market by Country, 2020 - 2023, USD Million
TABLE 39 LAMEA Fraud Detection and Prevention Market by Country, 2024 - 2031, USD Million
TABLE 40 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 41 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 42 LAMEA Clinical Risk Grouping Solution Market by Country, 2020 - 2023, USD Million
TABLE 43 LAMEA Clinical Risk Grouping Solution Market by Country, 2024 - 2031, USD Million
TABLE 44 Brazil Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 45 Brazil Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 46 Brazil Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 47 Brazil Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 48 Brazil Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 49 Brazil Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 50 Brazil Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 51 Brazil Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 52 Brazil Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 53 Brazil Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 54 Argentina Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 55 Argentina Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 56 Argentina Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 57 Argentina Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 58 Argentina Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 59 Argentina Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 60 Argentina Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 61 Argentina Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 62 Argentina Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 63 Argentina Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 64 UAE Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 65 UAE Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 66 UAE Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 67 UAE Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 68 UAE Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 69 UAE Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 70 UAE Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 71 UAE Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 72 UAE Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 73 UAE Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 74 Saudi Arabia Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 75 Saudi Arabia Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 76 Saudi Arabia Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 77 Saudi Arabia Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 78 Saudi Arabia Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 79 Saudi Arabia Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 80 Saudi Arabia Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 81 Saudi Arabia Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 82 Saudi Arabia Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 83 Saudi Arabia Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 84 South Africa Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 85 South Africa Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 86 South Africa Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 87 South Africa Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 88 South Africa Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 89 South Africa Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 90 South Africa Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 91 South Africa Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 92 South Africa Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 93 South Africa Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 94 Nigeria Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 95 Nigeria Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 96 Nigeria Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 97 Nigeria Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 98 Nigeria Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 99 Nigeria Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 100 Nigeria Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 101 Nigeria Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 102 Nigeria Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 103 Nigeria Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 104 Rest of LAMEA Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 105 Rest of LAMEA Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 106 Rest of LAMEA Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 107 Rest of LAMEA Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 108 Rest of LAMEA Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 109 Rest of LAMEA Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 110 Rest of LAMEA Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 111 Rest of LAMEA Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 112 Rest of LAMEA Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 113 Rest of LAMEA Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 114 Key Information -Conduent, Incorporated
TABLE 115 Key Information - 3M Company
TABLE 116 Key Information - Oracle Corporation
TABLE 117 Key Information - Microsoft Corporation
TABLE 118 Key Information - Health Catalyst, Inc.
TABLE 119 Key Information - Koninklijke Philips N.V.
TABLE 120 Key Information - Siemens Healthineers AG
TABLE 121 Key Information - HBI Solutions
TABLE 122 Key Information - Lightbeam Health Solutions
TABLE 123 Key Information - Reveleer

LAMEA Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents